Ms Stem Cells Canada

Multiple sclerosis journal 2017.

Ms stem cells canada.

Sarkar p et al. Pilot trial of intravenous autologous culture expanded mesenchymal stem cell transplantation in multiple sclerosis. Epub ahead of print summary. Canada has among the highest rates of ms in the world.

A research study in mice by investigators at the university of rochester medical center urmc suggests it would be possible to repair the brain cell damage caused by multiple sclerosis ms. Mesenychmal stem cells are found in many parts of the body including the bone marrow skin and fat. The discovered potential of msc in treating ms has culminated in the launch of mescams mesenchymal stem cell therapy for canadian ms patients a phase ii clinical trial that is funded in part by the ms scientific research foundation research manitoba and a w food services of canada inc. Stem cell therapy is any treatment that uses or targets stem cells which are the types of cells that differentiate into many different specialized cells in our bodies.

They have been shown to suppress inflammation and repair nerve tissue positioning them as promising candidates for the treatment of ms. The research was published in the journal cell reports. Mark freedman ottawa hospital research. One trial of 24 people with rrms found that 69 who had stem cell therapy didn t have a relapse in ms symptoms or new brain lesions which are caused by ms 5 years after treatment.

Mark freedman ottawa hospital. Many types of stem cells are being explored for their potential benefits for treating multiple sclerosis. Cohen ja et al. Stem cells are found in both embryos and adults.

Those patients with very aggressive multiple sclerosis that a stem cell transplant changes the course of the disease says dr. The research led by steve goldman professor of neurology and neuroscience at urmc and co director of the center for translational neuromedicine. That compared with only three of 55 patients given a stem cell transplant. The ms society of canada has announced funding for the first clinical trial of its kind in canada studying the ability of mesenchymal stem cells to treat ms.